Literature DB >> 7831820

Multiple determinants for growth of human immunodeficiency virus type 1 in monocyte-macrophages.

A Malykh1, M S Reitz, A Louie, L Hall, F Lori.   

Abstract

Attempts to define the genetic determinants required for efficient growth of human immunodeficiency virus type 1 (HIV-1) in monocyte-macrophages were made by constructing chimeras between two infectious clones of HIV-1 (HXB2 and LW/C), which despite only minor differences in their DNA sequence have striking differences in cell tropism. Although both of them replicate efficiently in peripheral blood mononuclear cells, HXB2 replicates extensively in permanent T cell lines but poorly in primary monocyte macrophages (T cell line tropic); the reverse is true for LW/C (macrophage tropic). The envelope proved to contain the major determinants of macrophage tropism. However, tropism determinants appeared to be scattered along the envelope. In particular, the V3 loop alone appeared to be neither necessary nor sufficient for growth in macrophages. Both vpr and nef genes appeared to play a less significant role to improve viral replication in macrophages, but only in the presence of the proper envelope sequences. HIV-1 macrophage tropism thus appears to result from the contribution of several different determinants.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831820     DOI: 10.1016/s0042-6822(95)80082-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Host-cell-specific glycosylation of HIV-2 envelope glycoprotein.

Authors:  S Liedtke; R Geyer; H Geyer
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

2.  Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes.

Authors:  B Chesebro; K Wehrly; J Nishio; S Perryman
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

Review 3.  How does HIV-1 infect a susceptible human cell?: Current thinking.

Authors:  Ali A Al-Jabri
Journal:  J Sci Res Med Sci       Date:  2003-08

4.  Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.

Authors:  M T Dittmar; G Simmons; Y Donaldson; P Simmonds; P R Clapham; T F Schulz; R A Weiss
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages.

Authors:  Brandon L Walter; Kathy Wehrly; Ronald Swanstrom; Emily Platt; David Kabat; Bruce Chesebro
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro.

Authors:  J Chang; H M Naif; S Li; J S Sullivan; C M Randle; A L Cunningham
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins.

Authors:  H M Naif; S Li; M Alali; J Chang; C Mayne; J Sullivan; A L Cunningham
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism.

Authors:  E D Miller; K M Duus; M Townsend; Y Yi; R Collman; M Reitz; L Su
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay.

Authors:  V Trouplin; F Salvatori; F Cappello; V Obry; A Brelot; N Heveker; M Alizon; G Scarlatti; F Clavel; F Mammano
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line.

Authors:  J M Harouse; R G Collman; F González-Scarano
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.